Daniel J. Hicklin
Board Member
Werewolf Therapeutics, Inc. (HOWL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel J. Hicklin
Daniel J. Hicklin is recorded as Board Member and CEO at Werewolf Therapeutics, Inc. (HOWL). The proxy statement of Werewolf Therapeutics, Inc. reports total compensation of $2,545,599 for Daniel J. Hicklin in fiscal 2024, including a base salary of $608,237. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Werewolf Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Urban CFO
- Reid Leonard COO
- Chulani Karunatilake CTO
- Anil Singhal, Ph.D. Board Member
- Meeta Chatterjee, Ph.D. Board Member
- Michael A. Sherman Board Member
- Michael B. Atkins Board Member
- Michael B. Atkins, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Werewolf Therapeutics, Inc. (HOWL) | President and Chief Executive Officer | $608,237 | $2,545,599 |
| 2023 | Werewolf Therapeutics, Inc. (HOWL) | President and Chief Executive Officer | $583,440 | $1,366,904 |
| 2022 | Werewolf Therapeutics, Inc. (HOWL) | President and Chief Executive Officer | $530,400 | $2,474,896 |
| 2021 | Werewolf Therapeutics, Inc. (HOWL) | President and Chief Executive Officer | $498,466 | $2,462,548 |
| 2020 | Werewolf Therapeutics, Inc. (HOWL) | President and Chief Executive Officer | $425,000 | $2,989,923 |
Recent activity
No call appearances or filed executive changes recorded yet.